Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Fibrosis × Tenofovir × Clear all

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 6 Hepatitis B, Chronic 4 Lymphoma 2 Hepatitis B 2 Virus Diseases 1 Recurrence 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Infections 1 Fibrosis 1 Epstein-Barr Virus Infections 1 Burkitt Lymphoma 1

Interventions

Blood Specimen Collection 7 Pentoxifylline 4 Liver Transplantation 4 Magnetic Resonance Spectroscopy 3 Tocopherols 2 Low-Level Light Therapy 2 High-Energy Shock Waves 2 tremelimumab 1 sonidegib 1 maltodextrin 1 epigallocatechin gallate 1 durvalumab 1 contrast agent BR1 1 bavituximab 1 apixaban 1 alpha-Tocopherol 1 Vitamin E 1 Vitamin D 1 User-Centered Design 1 Tenofovir 1 Surveys and Questionnaires 1 Sunitinib 1 Standard of Care 1 Spermine Synthase 1 Specimen Handling 1 Sorafenib 1 Sonazoid 1 Sodium Chloride 1 Sampling Studies 1 Restraint, Physical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02129829 2020-09-28

WATCH

Imperial College London

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡